tokens: The continuing development of ligands that function as selective estrogens or antiestrogens for ERalpha or ERbeta should allow optimized tissue selectivity of these agents for menopausal hormone replacement therapy and the treatment and prevention of breast cancer .
folded_tokens: the continue development of ligand that function as selective estrogen or antiestrogen for eralpha or erbeta should allow optimize tissue selectivity of these agent for menopausal hormone replacement therapy and the treatment and prevention of breast cancer .